Haeffener Mauren Porto, Ferreira Glória Menz, Barreto Sérgio Saldanha Menna, Arena Ross, Dall'Ago Pedro
Post-graduate Program in Cardiology and Cardiovascular Sciences, UFRGS, Porto Alegre, Rio Grande do Sul, Brazil.
Am Heart J. 2008 Nov;156(5):900.e1-900.e8. doi: 10.1016/j.ahj.2008.08.006. Epub 2008 Oct 5.
The use of the incentive spirometry (IS) with expiratory positive airway pressure (EPAP) to prevent postoperative pulmonary complications (PPC) after coronary artery bypass graft (CABG) is not well established. This study sought to determine the effects of IS+EPAP after CABG.
Thirty-four patients undergoing CABG were randomly assigned to a control group or IS+EPAP group. Maximal respiratory pressures, pulmonary function test, 6-minute walk test and chest x-ray were performed at baseline as well as 1 week and 1 month after CABG.
Maximal inspiratory pressure was significantly higher in the IS+EPAP group compared to controls at both 1 week and 1 month (P<.001). Maximal expiratory pressure was significantly higher at 1 month compared to 1 week in IS+EPAP group (P<.01). At 1 month, forced vital capacity and forced expiratory volume in 1 second was significantly higher in IS+EPAP compared to controls (P<.05). Inspiratory capacity was higher at 1 month in IS+EPAP group compared to controls (P<.05). The distance walked in 6-minute walk test was higher at 1 month in IS+EPAP group (P<.001) compared to controls. Lastly, radiological injury score at 1 week was lower in IS+EPAP compared to controls (P<.004).
In patients undergoing CABG, IS+EPAP results in improved pulmonary function and 6-minute walk distance as well as a reduction in PPC.
在冠状动脉旁路移植术(CABG)后使用带有呼气末正压(EPAP)的激励肺活量测定法(IS)来预防术后肺部并发症(PPC)尚未得到充分证实。本研究旨在确定CABG后IS+EPAP的效果。
34例行CABG的患者被随机分为对照组或IS+EPAP组。在基线以及CABG后1周和1个月时进行最大呼吸压力、肺功能测试、6分钟步行试验和胸部X光检查。
IS+EPAP组在1周和1个月时的最大吸气压力均显著高于对照组(P<0.001)。IS+EPAP组在1个月时的最大呼气压力显著高于1周时(P<0.01)。在1个月时,IS+EPAP组的用力肺活量和1秒用力呼气量显著高于对照组(P<0.05)。IS+EPAP组在1个月时的吸气量高于对照组(P<0.05)。与对照组相比,IS+EPAP组在1个月时的6分钟步行试验中行走的距离更长(P<0.001)。最后,IS+EPAP组在1周时的放射学损伤评分低于对照组(P<0.004)。
在接受CABG的患者中,IS+EPAP可改善肺功能和6分钟步行距离,并减少PPC。